These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1356776)

  • 1. Effect of a new multifactorial antihypertensive on heart morphology and function in mild to moderate essential arterial hypertension.
    Genovesi-Ebert A; Marabotti C; Palombo C; Ghione S; Cattaneo G; Noseda A; Spinazzi A
    Eur Heart J; 1992 Jun; 13 Suppl A():45-8. PubMed ID: 1356776
    [No Abstract]   [Full Text] [Related]  

  • 2. Favourable haemodynamic effects of a new multifactorial antihypertensive on left ventricular dimension, wall thickness and function in hypertensive patients.
    Sheiban I; Arosio E; Tonni S; Montresor G; Priante F; Lechi A
    Eur Heart J; 1992 Jun; 13 Suppl A():37-44. PubMed ID: 1356775
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of a new multifactorial antihypertensive on blood pressure and metabolic profile in essential hypertension associated with non-insulin-dependent diabetes mellitus.
    Fariello R; Boni E; Corda L; Zaninelli A; Noseda A; Spinazzi A
    Eur Heart J; 1992 Jun; 13 Suppl A():65-9. PubMed ID: 1356779
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of antihypertensive therapy on left ventricular hypertrophy in essential hypertension.
    Frohlich ED
    Adv Nephrol Necker Hosp; 1990; 19():87-100. PubMed ID: 1967894
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical pharmacology, efficacy and safety of a new alpha 1 adrenoceptor antagonist with an additional central action, in hypertension.
    Man in 't Veld AJ
    Eur Heart J; 1992 Jun; 13 Suppl A():58-60. PubMed ID: 1356778
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of antihypertensive treatment on left ventricular hypertrophy in patients with essential hypertension.
    Yamada T; Kubota T; Endo T; Komatus H; Oba M; Nagata H; Izumiyama T
    J Am Geriatr Soc; 1979 Nov; 27(11):500-6. PubMed ID: 158604
    [No Abstract]   [Full Text] [Related]  

  • 7. [Possibilities of reverse development of left-ventricular hypertrophy in hypertension].
    Bakhshaliev AB; Akhmetzianova EKh; Gadzhiev RF; Teboeva RV
    Klin Med (Mosk); 1989 Mar; 67(3):10-7. PubMed ID: 2526273
    [No Abstract]   [Full Text] [Related]  

  • 8. Doxazosin in the treatment of mild or moderate essential hypertension: an echocardiographic study.
    Corral JL; López NC; Pecorelli A; Rincón LA; Terán VD
    Am Heart J; 1991 Jan; 121(1 Pt 2):352-6. PubMed ID: 1824660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of left ventricular hypertrophy after longterm antihypertensive treatment with doxazosin.
    Agabiti-Rosei E; Muiesan ML; Rizzoni D; Zulli R; Calebich S; Beschi M; Castellano M; Muiesan G
    J Hum Hypertens; 1992 Feb; 6(1):9-15. PubMed ID: 1349920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression of left ventricular hypertrophy in patients with essential hypertension: outcome of 12 years antihypertensive treatment.
    Shigematsu S; Hiramatsu K; Aizawa T; Yamada T; Takasu N; Niwa A; Miyahara Y; Tsujino M; Shimizu Z
    Cardiology; 1990; 77(4):280-6. PubMed ID: 1981491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect on resting blood pressure and blood pressure homeostasis of short-term administration of the alpha 1-adrenergic receptor antagonist, trimazosin, in hypertension.
    Sampieri L; Cuspidi C; Boselli L; Angioni L; Castiglioni G; Zanchetti A; Mancia G
    Cardiovasc Drugs Ther; 1988 Jan; 1(5):535-42. PubMed ID: 2908716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of antihypertensive treatment on the thickening of the basal portion of the interventricular septum in essential hypertension].
    Sakurai S; Ashida T; Takahashi N; Fujii J
    J Cardiol; 1998 Mar; 31(3):151-8. PubMed ID: 9557278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The regression of left ventricular hypertrophy following a short antihypertensive treatment].
    Soria F; Alegría E; Valdés M; García A; Vicente T; Apellaniz G
    Rev Esp Cardiol; 1991; 44(6):389-94. PubMed ID: 1833800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha Adrenergic Blockers in the Treatment of Hypertension--A Nephrologist's Perspective.
    Taraphder A
    J Assoc Physicians India; 2014 Sep; 62(9 Suppl):30-3. PubMed ID: 26245040
    [No Abstract]   [Full Text] [Related]  

  • 15. Guidelines for arterial hypertension: the echocardiography controversy.
    de Simone G
    J Hypertens; 1999 Jun; 17(6):735-6. PubMed ID: 10459868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hybrid or multifactorial drugs in antihypertensive treatment.
    van Zwieten PA
    J Hypertens; 1990 Aug; 8(8):687-96. PubMed ID: 1976690
    [No Abstract]   [Full Text] [Related]  

  • 17. [Alpha beta-blockers for patients with hypertension].
    Mizuta Y; Imaizumi T
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():305-9. PubMed ID: 16981560
    [No Abstract]   [Full Text] [Related]  

  • 18. Ergometry as a basis for judging the antihypertensive effect.
    Franz IW; Tönnesmann U; Erb D; Ketelhut R
    Drugs; 1990; 40 Suppl 4():54-7. PubMed ID: 2092968
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapy of hypertensive hypertrophy.
    Motz W; Strauer BE
    Scand J Clin Lab Invest Suppl; 1989; 196():62-71. PubMed ID: 2530623
    [No Abstract]   [Full Text] [Related]  

  • 20. Echocardiographic left ventricular hypertrophy in hypertension.
    Drayer JI; Gardin JM; Weber MA
    Chest; 1983 Aug; 84(2):217-21. PubMed ID: 6223791
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.